Advertisement
Screener

Tengjun Biotechnology Corp. Advertising Expense

Tengjun Biotechnology Corp. Advertising Expense

Tengjun Biotechnology Corp. reported Advertising Expense of $123.16 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AdvertisingExpense · last filed 2023-04-17

  • Tengjun Biotechnology Corp. advertising expense for the quarter ending 2022-12-31 was $123.15M, a 3811508.14% increase year-over-year.
  • Tengjun Biotechnology Corp. advertising expense for the quarter ending 2022-09-30 was $316.00, a 96.33% decline year-over-year.
  • Tengjun Biotechnology Corp. advertising expense for the quarter ending 2022-06-30 was $2.93K, a 77.80% decline year-over-year.
  • Tengjun Biotechnology Corp. advertising expense for the quarter ending 2022-03-31 was $1.23K.
  • Tengjun Biotechnology Corp. advertising expense for fiscal 2022 was $123.16M, a 432046.84% increase from fiscal 2021.
  • Tengjun Biotechnology Corp. advertising expense for fiscal 2021 was $28.50K.
Period endAdvertising Expense 3 monthAdvertising Expense 6 monthAdvertising Expense 9 monthAdvertising Expense 12 month
2022-12-31$123.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$123.15M
derived: sum of 2 quarters · filed 2023-04-17
$123.16M
derived: sum of 3 quarters · filed 2023-04-17
$123.16M
10-K · filed 2023-04-17
2022-09-30$316.00
10-Q · filed 2022-11-14
$3.24K
derived: sum of 2 quarters · filed 2022-11-14
$4.47K
10-Q · filed 2022-11-14
$7.70K
derived: sum of 4 quarters · filed 2023-04-17
2022-06-30$2.93K
10-Q/A · filed 2022-09-16
$4.15K
10-Q/A · filed 2022-09-16
$7.38K
derived: sum of 3 quarters · filed 2023-04-17
$16.01K
derived: sum of 4 quarters · filed 2023-04-17
2022-03-31$1.23K
derived: 10-K 12 month − 3 quarters · filed 2023-04-17
$4.46K
derived: sum of 2 quarters · filed 2023-04-17
$13.08K
derived: sum of 3 quarters · filed 2023-04-17
$26.27K
derived: sum of 4 quarters · filed 2023-04-17
2021-12-31$3.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$11.85K
derived: sum of 2 quarters · filed 2023-04-17
$25.04K
derived: sum of 3 quarters · filed 2023-04-17
$28.50K
10-K · filed 2023-04-17
2021-09-30$8.62K
10-Q · filed 2022-11-14
$21.81K
derived: sum of 2 quarters · filed 2022-11-14
$25.27K
10-Q · filed 2022-11-14
2021-06-30$13.19K
10-Q/A · filed 2022-09-16
$16.65K
10-Q/A · filed 2022-09-16